The Real World Experience with Lecanemab: A US Case Study

Findings from this survey study will evaluate patient-reported outcomes and treatment satisfaction associated with lecanemab in real-world settings. Understanding the impact on patients' and care partners' lives may inform treatment decisions.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2025-12-01
DOI
https://doi.org/10.1002/alz70858_102096
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Real World Experience with Lecanemab: A US Case Study

Rosa Hart, Whoy Shang, Hannah Hust
Alzheimer s & Dementia
Dementia and Cognitive Impairment Research
article

The Real World Experience with Lecanemab: A US Case Study

Rosa Hart, Whoy Shang, Hannah Hust
article en

Abstract

Findings from this survey study will evaluate patient-reported outcomes and treatment satisfaction associated with lecanemab in real-world settings. Understanding the impact on patients' and care partners' lives may inform treatment decisions.

Alzheimer s & DementiaVol. 21(S4)
Norton Healthcare (US)
Openalex Percentile: Top 33%
Dementia and Cognitive Impairment Research
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

The Real World Experience with Lecanemab: A US Case Study — Rosa Hart, Whoy Shang, et al. · Alzheimer s & Dementia (2025) | TGRS Research Map | TGRS